# Clustering Approach 7 : MIRSEQ_CHIERARCHICAL
Index	Clinical feature name	Test type	P value	Comment
1	Time to Death	logrank test	0.646592568040914	Range of duration = 0.03 to 76.21, nDeath = 27, nCensor = 53
2	AGE	ANOVA	0.0284157942445189	Range of values = 38 to 85, Mean = 65.2025, StdDev = 9.70643, nMissing = 16
3	GENDER	Fisher's exact test	0.302604450465203	nTypes = 2 (FEMALE/MALE), nPatients = 43/52
4	KARNOFSKY.PERFORMANCE.SCORE	ANOVA	NA	Range of values = 0 to 100, Mean = 75, StdDev = 37.2827, nMissing = 89
5	HISTOLOGICAL.TYPE	Chi-square test	0.0594118435395661	nTypes = 6 (LUNG ADENOCARCINOMA MIXED SUBTYPE/LUNG ADENOCARCINOMA- NOT OTHERWISE SPECIFIED (NOS)/LUNG BRONCHIOLOALVEOLAR CARCINOMA NONMUCINOUS/LUNG CLEAR CELL ADENOCARCINOMA/LUNG PAPILLARY ADENOCARCINOMA/MUCINOUS (COLLOID) ADENOCARCINOMA), nPatients = 19/68/2/1/3/2
6	PATHOLOGY.T	Chi-square test	0.698611097985963	nTypes = 4 (T1/T2/T3/T4), nPatients = 27/59/6/3
7	PATHOLOGY.N	Chi-square test	0.871593405253085	nTypes = 3 (N0/N1/N2+N3), nPatients = 55/22/16, nMissing = 2
8	PATHOLOGICSPREAD(M)	Chi-square test	0.0539125727721149	nTypes = 3 (M0/M1/MX), nPatients = 76/5/13, nMissing = 1
9	RADIATIONS.RADIATION.REGIMENINDICATION	Fisher's exact test	0.558198172163409	nTypes = 2 (NO/YES), nPatients = 91/4
10	NEOADJUVANT.THERAPY	Fisher's exact test	0.858687929709205	nTypes = 2 (NO/YES), nPatients = 83/12